Completed NA INTERVENTIONAL 2-arm NCT01941576

Effects of rhBNP in Pediatrics After Corrective Repair of Tetralogy Of Fallot

Sponsor: Shanghai Jiao Tong University School of Medicine

Conditions Congenital Heart Defects Tetralogy Of Fallot

Interventions Placebo (0.9% sodium chloride) recombinant human brain natriuretic peptide (rhBNP)

Updated 7 times since 2017 Last updated: Oct 26, 2020 Started: Sep 1, 2013 Primary completion: Dec 31, 2017 Completion: Jul 20, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Congenital Heart Defects and Tetralogy Of Fallot and is currently completed. Shanghai Jiao Tong University School of Medicine leads this study, which shows 7 recorded versions since 2013 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Nov 2020 — Jan 2021 [monthly]

Completed NA

Status: Unknown Status → Completed · Phase: PHASE2_PHASE3 → NA
Jun 2018 — Nov 2020 [monthly]

Unknown Status PHASE2_PHASE3

▶ Show 2 earlier versions

Feb 2018 — Jun 2018 [monthly]

Unknown Status PHASE2_PHASE3

Status: Recruiting → Unknown Status
Jan 2017 — Feb 2018 [monthly]

Recruiting PHASE2_PHASE3

First recorded

Sep 2013

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Shanghai Jiao Tong University School of Medicine

Data source: Shanghai Jiao Tong University School of Medicine

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Shanghai, China